These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32681791)

  • 1. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
    Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
    Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
    Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
    Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
    Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
    AboulWafa OM; Daabees HMG; Badawi WA
    Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oxadiazole-thiadiazole derivatives: synthesis, biological evaluation, and
    Evren AE; Nuha D; Dawbaa S; Karaduman AB; Sağlik BN; Yurttaş L
    J Biomol Struct Dyn; 2024 Oct; 42(16):8688-8700. PubMed ID: 37587853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, In vitro and In silico Studies of Novel Bis-triazolopyridopyrimidines from Curcumin Analogues as Potential Aromatase Agents.
    Gomha SM; El-Sayed AAA; Zaki MEA; Alrehaily A; Elbadawy HM; Al-Shahri ABA; Alsenani SR; Abouzied AS
    Chem Biodivers; 2024 Aug; 21(8):e202400701. PubMed ID: 38829745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New enantioenriched β-indolyl ketones as aromatase inhibitors: Unraveling heme-ligand interactions by MD simulation and MMPBSA analysis.
    Pasha MH; Gondal HY; Munir S; Alhussain SA; Zaki MEA
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400010. PubMed ID: 38578079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
    Sahin Z; Ertas M; Berk B; Biltekin SN; Yurttas L; Demirayak S
    Bioorg Med Chem; 2018 May; 26(8):1986-1995. PubMed ID: 29525337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
    Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
    Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
    Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.